Importance An estimated 1.1 million individuals in the United States are currently living with
HIV, and more than 700 000 persons have died of AIDS since the first cases were reported …

Importance Effective prevention strategies for HIV infection are an important public health
priority. Preexposure prophylaxis (PrEP) involves use of antiretroviral therapy (ART) daily or …

As the global incidence of HIV exceeds 2 million new infections annually, effective
interventions to decrease HIV transmission are needed. Randomized, placebo-controlled …

Background. The combination of tenofovir and emtricitabine shows promise as HIV
preexposure prophylaxis (PrEP). We sought to forecast clinical, epidemiologic, and …

Importance About 40 000 Americans and 2 million people worldwide are newly infected with
HIV each year. The combination antiretroviral regimen, tenofovir disoproxil fumarate …

Importance A 2019 review for the US Preventive Services Task Force (USPSTF) found oral
preexposure prophylaxis (PrEP) associated with decreased HIV infection risk vs placebo or …

Albert Liu and colleagues report early experiences with uptake and delivery of pre-exposure
prophylaxis (PrEP) for HIV prevention in three different settings in San Francisco. PrEP can …

AN ESTIMATED 11 000 NEW HUMAN IMMUNODEFI-ciency virus (HIV) infections occur
worldwide per day and approximately 4 million individuals are infected with HIV per year. 1 …

Preexposure prophylaxis (PrEP) with tenofovir/emtricitabine (slash indicates coformulation)
is highly effective in preventing new HIV infections. PrEP efficacy is strongly associated with …

Preexposure prophylaxis (PrEP), in which HIV-uninfected persons with ongoing HIV risk use
antiretroviral medications to reduce their risk of acquiring HIV infection, is an efficacious and …